Mather Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2
Closed -$93 2085
2024
Q2
$93 Buy
+2
New +$93 ﹤0.01% 2145